REAL-WORLD TREATMENT PATTERN IN COMMUNITY PATIENTS WITH TYPE-2 DIABETES: EVIDENCE FROM SHANGHAI, CHINA

被引：0
|
作者：
Gao, Y. [1 ]
Chen, L. [2 ]
Fang, H. [2 ]
Xu, D. [2 ]
Xuan, J. [3 ]
Liu, B. [4 ]
机构：
[1] Shanghai Centennial Sci Ltd, Shanghai, Peoples R China
[2] Shanghai Minhang Ctr Dis Control & Prevent, Shanghai, Peoples R China
[3] Sun Yat Sen Univ, Guangzhou, Guangdong, Peoples R China
[4] Fudan Univ, Sch Publ Hlth, Dept Hlth Econ, Shanghai, Peoples R China
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.1917
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB85
引用
收藏
页码：A680 / A680
页数：1
相关论文
共 50 条
  • [21] Elderly Latino Patients with Type 2 Diabetes: A Real-World Perspective
    Cagide, Ana L.
    Giunta, Diego H.
    Bader, Giovanni
    Paldanius, Paivi M.
    Mendivil, Carlos O.
    DIABETES, 2016, 65 : A289 - A289
  • [22] Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from SemaglUtide Real-world Evidence (SURE) Germany
    Menzen, Markus
    Berentzen, Tina Landsvig
    Catarig, Andrei-Mircea
    Pieperhoff, Sebastian
    Simon, Joerg
    Jacob, Stephan
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2023, 131 (04) : 205 - 215
  • [23] Effect of Diabetes Treatment-Related Attributes on Costs to Type 2 Diabetes Patients in a Real-World Population
    Meng, Jie
    Casciano, Roman
    Lee, Yi-Chien
    Stern, Lee
    Gultyaev, Dmitry
    Tong, Liyue
    Kitio-Dschassi, Brice
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (04): : 428 - 434
  • [24] Treatment for Patients with Type-2 Diabetes
    Landgraf, Ruediger
    Kellerer, Monika
    Aberle, Jens
    Fach, Eva-Maria
    Gallwitz, Baptist
    Hamann, Andreas
    Joost, Hans-Georg
    Klein, Harald
    Mueller-Wieland, Dirk
    Nauck, Michael A.
    Reuter, Hans-Martin
    Schreiber, Stephan
    Siegel, Erhard
    DIABETOLOGE, 2019, 15 (02): : 146 - 167
  • [25] Treatment for Patients with Type-2 Diabetes
    Landgraf, Rueediger
    Aberle, Jens
    Birkenfeld, Andreas L.
    Gallwitz, Baptist
    Kellerer, Monika
    Klein, Harald H.
    Mueller-Wieland, Dirk
    Nauck, Michael A.
    Wiesner, Tobias
    Siegel, Erhard
    DIABETOLOGIE UND STOFFWECHSEL, 2021, 16 : S168 - S206
  • [26] Drug utilisation pattern over 3 years in the real-world treatment of type II diabetes
    Romagnoli, Alessia
    Santoleri, Fiorenzo
    Costantini, Alberto
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (06)
  • [27] Value And Challenges Of Investigating Real-world Effectiveness Of Exercise Physiology Services For Type-2 Diabetes
    Davison, Kade
    Selig, Steve
    Parmenter, Belinda
    Best, Tania
    Fraiser, Steve
    Schneider, Silvia
    Cheney, Michael
    Hodonu, Jack
    Pitcher, Christian
    Furzer, Bonnie
    Cesnik, Rebecca
    Hardcastle, Sibella
    Kitic, Cecilia
    Williams, Andrew
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2020, 52 (07) : 135 - 135
  • [28] Real-world evidence studies into treatment adherence, thresholds for intervention and disparities in treatment in people with type 2 diabetes in the UK
    McGovern, Andrew
    Hinton, William
    Correa, Ana
    Munro, Neil
    Whyte, Martin
    de Lusignan, Simon
    BMJ OPEN, 2016, 6 (11):
  • [29] Real-World Treatment Patterns Among Patients with Type 2 Diabetes Mellitus Initiating Treatment with Oral Semaglutide
    Swift, Caroline
    Frazer, Monica S.
    Gronroos, Noelle N.
    Sargent, Andrew
    Leszko, Michael
    Buysman, Erin
    Alvarez, Sara
    Dunn, Tyler J.
    Noone, Josh
    Guevarra, Mico
    DIABETES THERAPY, 2024, 15 (07) : 1547 - 1559
  • [30] Clinical Inertia in Type 2 Diabetes Management: Evidence From a Large, Real-World Data Set
    Pantalone, Kevin M.
    Misra-Hebert, Anita D.
    Hobbs, Todd M.
    Ji, Xinge
    Kong, Sheldon X.
    Milinovich, Alex
    Weng, Wayne
    Bauman, Janine
    Ganguly, Rahul
    Burguera, Bartolome
    Kattan, Michael W.
    Zimmerman, Robert S.
    DIABETES CARE, 2018, 41 (07) : E113 - E114
12345